(Q37563986)

21 August 2017

1 reference

title

The pathogenesis and treatment of chronic allograft nephropathy (English)

1 reference

21 August 2017

0 references

Can Li

1

1 reference

PubMed ID

19636333

21 August 2017

Chul Woo Yang

series ordinal

2

1 reference

PubMed ID

19636333

21 August 2017

language of work or name

English

0 references

publication date

28 July 2009

1 reference

Nature Reviews Nephrology

21 August 2017

1 reference

21 August 2017

5

1 reference

21 August 2017

9

1 reference

21 August 2017

513-519

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2009.113

21 August 2017

0 references

cites work

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

The natural history of chronic allograft nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

The variable nature of chronic declines in renal allograft function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Banff 07 classification of renal allograft pathology: updates and future directions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Chronic renal allograft rejection: immunologic and nonimmunologic risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

The impact of an acute rejection episode on long-term renal allograft survival (t1/2)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Impact of acute rejection and early allograft function on renal allograft survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Diabetes mellitus after kidney transplantation in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Risk factors predicting chronic rejection of renal allografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Angiotensin converting enzyme inhibition in chronic allograft nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Early development of accelerated graft coronary artery disease: risk factors and course

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Differential diagnosis between infection and rejection in renal allografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

BK virus infection in a kidney allograft diagnosed by needle biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Human Polyomavirus Infections with JC Virus and BK Virus in Renal Transplant Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Causes of graft loss beyond two years in the cyclosporine era

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Immunohistologic analysis of human renal allograft dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

The long-term course of cyclosporine-associated chronic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Clinical and histological analysis of chronic tacrolimus nephrotoxicity in renal allografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Natural history, risk factors, and impact of subclinical rejection in kidney transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Inhibitory effect of pravastatin on transforming growth factor beta1-inducible gene h3 expression in a rat model of chronic cyclosporine nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Blockade of angiotensin II with losartan attenuates transforming growth factor-beta1 inducible gene-h3 (betaig-h3) expression in a model of chronic cyclosporine nephrotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Prolonged endoplasmic reticulum stress induces apoptotic cell death in an experimental model of chronic cyclosporine nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Chronic cyclosporine nephrotoxicity: new insights and preventive strategies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Colchicine decreases apoptotic cell death in chronic cyclosporine nephrotoxicity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Cyclosporine-induced renal injury induces toll-like receptor and maturation of dendritic cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Influence of angiotensin II on expression of toll-like receptor 2 and maturation of dendritic cells in chronic cyclosporine nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Effect of FTY720 on chronic cyclosporine nephropathy in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Infiltration of nestin-expressing cells in interstitial fibrosis in chronic cyclosporine nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Histopathological findings in well-functioning, long-term renal allografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Long-term consequences of different immunosuppressive regimens for renal allografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Chronic renal allograft dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Characterization of intra-graft B cells during renal allograft rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Costimulation blockade with belatacept in renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Concentration-controlled everolimus (Certican): combination with reduced dose calcineurin inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Reduced exposure to calcineurin inhibitors in renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Immunomodulation: a new role for statins?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Statins as a newly recognized type of immunomodulator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) in renal transplant patients resistant to HMG-CoA reductase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Strategies to improve long-term outcomes after renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Humoral theory of transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.113

Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine

31 March 2020

1 reference

12 December 2020

Rethinking chronic allograft nephropathy: the concept of accelerated senescence.

1 reference

12 December 2020

Absence of association between cytomegalovirus infection and obliterative transplant arteriopathy in renal allograft rejection

1 reference

12 December 2020

Expression of apoptosis-related factors in chronic cyclosporine nephrotoxicity after cyclosporine withdrawal.

1 reference

12 December 2020

Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study

1 reference

12 December 2020

The hyperfiltration hypothesis in human renal transplantation

1 reference

12 December 2020

Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism

1 reference

12 December 2020

Significance of the donor age effect on kidney transplants.

1 reference

12 December 2020

Clinical correlation between renal allograft failure and hyperlipidemia

1 reference

12 December 2020

TGF-beta1 in chronic allograft nephropathy following renal transplantation

1 reference

12 December 2020

Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant

1 reference

12 December 2020

Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft

1 reference

12 December 2020

Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.

1 reference

12 December 2020

Anti-HLA class II antibodies and chronic allograft nephropathy

1 reference

12 December 2020

Effect of initial slow graft function on renal allograft rejection and survival

1 reference

12 December 2020

The effect of HMG-CoA reductase inhibitors on chronic allograft rejection

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2009.113

1 reference

21 August 2017

1 reference

PubMed ID

19636333